A Long-Acting HIV Prevention Shot Has Promise, but Access Still Lags
Lenacapavir may make HIV prevention easier for many people, but the latest reporting shows a familiar gap: regulatory progress is moving faster than real-world supply.
Cheaper Lenacapavir Could Expand HIV Prevention Abroad
A newly approved generic version of lenacapavir may make one of the newest HIV-prevention options more accessible in lower-income countries, while questions remain about rollout, supply and local approval.